Solutions Ecosystems Reports Resources Data Pricing Login Book a demo
Power Law company profile

EyePoint Pharmaceuticals

Biotech & Life Sciences · Watertown, United States · Founded 2000 · IPO 2005 Thoroughbred

Tiny, sustained-release drug delivery products designed to deliver drugs at a controlled and steady rate

Valuation
$821M
Market cap · May/2026
Revenue
$31M
Latest reported FY

Global footprint

Where EyePoint Pharmaceuticals has talent and traffic

Workforce by country
🇺🇸 United States · Watertown HQ
Book a demo for the full country breakdown
Web traffic by country
2.4K monthly visits
across markets
🇺🇸 United States170.8%
🇮🇳 India41.7%
Top 2 markets shown

Market sentiment

What the market is saying about EyePoint Pharmaceuticals

An AI-synthesized read of the highest-engagement posts about EyePoint Pharmaceuticals on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See EyePoint Pharmaceuticals on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.